Richard A E Edden1, Jarunee Intrapiromkul, He Zhu, Ying Cheng, Peter B Barker. 1. Division of Neuroradiology, Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA. raee2@jhu.edu
Abstract
PURPOSE: To develop an experimental approach for determining in vivo transverse relaxation rates (T(2)) of metabolites that are detected by spectral editing without using simulations, and to demonstrate this approach to measure the T(2) of γ-aminobutyric acid (GABA). MATERIALS AND METHODS: The proposed method first determines the TE-dependence of the edited signals using measurements in a pure phantom solution (10 mM γ-aminobutyric acid; GABA); the phantom T(2) is also determined. Once the editing echo time (TE)-modulation pattern is known, it can then be used to determine T(2) in vivo. The method was applied to measure GABA T(2) in the occipital lobe of five healthy adult subjects at 3T, using a J-difference editing method. Unwanted macromolecular contributions to the GABA signal were also measured. RESULTS: The in vivo T(2) of edited GABA signal was 88 ± 12 ms; this preliminary result is somewhat shorter than other metabolite T(2) values in the literature at this field strength. CONCLUSION: Spectral editing methods are now widely used to detect low concentration metabolites, such as GABA, but to date no edited acquisition methods have been proposed for the measurement of transverse relaxation times (T(2)). The method described has been successfully applied to measuring the T(2) of GABA.
PURPOSE: To develop an experimental approach for determining in vivo transverse relaxation rates (T(2)) of metabolites that are detected by spectral editing without using simulations, and to demonstrate this approach to measure the T(2) of γ-aminobutyric acid (GABA). MATERIALS AND METHODS: The proposed method first determines the TE-dependence of the edited signals using measurements in a pure phantom solution (10 mM γ-aminobutyric acid; GABA); the phantom T(2) is also determined. Once the editing echo time (TE)-modulation pattern is known, it can then be used to determine T(2) in vivo. The method was applied to measure GABA T(2) in the occipital lobe of five healthy adult subjects at 3T, using a J-difference editing method. Unwanted macromolecular contributions to the GABA signal were also measured. RESULTS: The in vivo T(2) of edited GABA signal was 88 ± 12 ms; this preliminary result is somewhat shorter than other metabolite T(2) values in the literature at this field strength. CONCLUSION: Spectral editing methods are now widely used to detect low concentration metabolites, such as GABA, but to date no edited acquisition methods have been proposed for the measurement of transverse relaxation times (T(2)). The method described has been successfully applied to measuring the T(2) of GABA.
Authors: Georg Northoff; Martin Walter; Rolf F Schulte; Johannes Beck; Ulrike Dydak; Anke Henning; Heinz Boeker; Simone Grimm; Peter Boesiger Journal: Nat Neurosci Date: 2007-11-04 Impact factor: 24.884
Authors: Changho Choi; Nicholas J Coupland; Paramjit P Bhardwaj; Sanjay Kalra; Colin A Casault; Kim Reid; Peter S Allen Journal: Magn Reson Med Date: 2006-11 Impact factor: 4.668
Authors: Zaiyang Long; Jonathan P Dyke; Ruoyun Ma; Chaorui C Huang; Elan D Louis; Ulrike Dydak Journal: NMR Biomed Date: 2015-08-28 Impact factor: 4.044
Authors: Mark Mikkelsen; Peter B Barker; Pallab K Bhattacharyya; Maiken K Brix; Pieter F Buur; Kim M Cecil; Kimberly L Chan; David Y-T Chen; Alexander R Craven; Koen Cuypers; Michael Dacko; Niall W Duncan; Ulrike Dydak; David A Edmondson; Gabriele Ende; Lars Ersland; Fei Gao; Ian Greenhouse; Ashley D Harris; Naying He; Stefanie Heba; Nigel Hoggard; Tun-Wei Hsu; Jacobus F A Jansen; Alayar Kangarlu; Thomas Lange; R Marc Lebel; Yan Li; Chien-Yuan E Lin; Jy-Kang Liou; Jiing-Feng Lirng; Feng Liu; Ruoyun Ma; Celine Maes; Marta Moreno-Ortega; Scott O Murray; Sean Noah; Ralph Noeske; Michael D Noseworthy; Georg Oeltzschner; James J Prisciandaro; Nicolaas A J Puts; Timothy P L Roberts; Markus Sack; Napapon Sailasuta; Muhammad G Saleh; Michael-Paul Schallmo; Nicholas Simard; Stephan P Swinnen; Martin Tegenthoff; Peter Truong; Guangbin Wang; Iain D Wilkinson; Hans-Jörg Wittsack; Hongmin Xu; Fuhua Yan; Chencheng Zhang; Vadim Zipunnikov; Helge J Zöllner; Richard A E Edden Journal: Neuroimage Date: 2017-07-14 Impact factor: 6.556
Authors: Kimberly L Chan; Nicolaas A J Puts; Karim Snoussi; Ashley D Harris; Peter B Barker; Richard A E Edden Journal: Magn Reson Med Date: 2016-02-25 Impact factor: 4.668
Authors: Ashley D Harris; Benjamin Glaubitz; Jamie Near; C John Evans; Nicolaas A J Puts; Tobias Schmidt-Wilcke; Martin Tegenthoff; Peter B Barker; Richard A E Edden Journal: Magn Reson Med Date: 2013-11-11 Impact factor: 4.668
Authors: Paul G Mullins; David J McGonigle; Ruth L O'Gorman; Nicolaas A J Puts; Rishma Vidyasagar; C John Evans; Richard A E Edden Journal: Neuroimage Date: 2012-12-13 Impact factor: 6.556